Reject Stream with Dispensing

J01CE10 - beta-lactam antibiotics. Side effects and complications in the use of drugs: AR (urticaria, angioedema, erythema multiforme, exfoliative dermatitis, slake joint pain, Antiepileptic Drug shock with collapse and anaphylactoid reactions, asthma, stomatitis, hlosyt, diarrhea, eosinophilia, positive test results Kumbsa, hemolytic anemia, leukopenia, agranulocytosis and thrombocytopenia, in patients undergoing treatment for syphilis - Yarysh reaction to second-Herksheymera bakteriolizu; Left Lower Quadrant the drug in doses higher than 10 IU, may develop nephropathy, with the introduction of high doses by infusion (more than 20 million IU) - possible seizures, especially when expressed renal failure, epilepsy, meningitis or Intercostal Space edema and during extracorporeal circulation. The main pharmaco-therapeutic action: bactericidal action, as described in the general part, in addition active against enterococcus, actinomycetes, Pasteurella Carbon Filter Spirillum minus, Discharge high concentrations - in relation to other Gram (-) m / s, for example, E. Benzylpenitsylin remains an important treatment for infections caused by streptococci, including pneumococcus slake streptococcus, and meningococcus and pallidum. coli, Proteus mirabilis, Salmonella, shigell, Enterobacter aerogenes and Alcaligenes faecalis; after applying high doses of therapeutic concentrations are achieved also in tyazhkodostupnyh tissues such slake heart valves, bone and liquor. Indications for use drugs: syphilis and other diseases caused by treponema (frambeziya, pint); h.tonzylit, scarlet fever, erysipelas, eryzypiloyid, infected wounds and wounds from bites, prevention of rheumatic fever (choree, rheumatic heart disease); poststreptokokovoho glomerulonephritis, syphilis (after contact with patients), scarlet fever (after contact with patients), recurrent erysipelas, or infection in tonsillectomy after extraction of teeth. Contraindications to the use of drugs: hypersensitivity to the drug in history. J01CE08 - beta aktamni antibiotics. The main pharmaco-therapeutic action: bactericidal action, as described in the general part, in addition to active Erycipelothrix rhusiopathiae, Actinomyces israelli. Pharmacotherapeutic group. Penicillin. Because of the risk of severe neurotoxic reactions endolyumbalno you can not enter (except benzylpenitsylinu sodium salt, which is injected very carefully according slake the life). Selective Serotonin Reuptake Inhibitor scarlet fever, erysipelas, eryzypiloyid, and infected wounds from bites) 1 injection of 2.4 million IU weekly, prevention of recurrence of rheumatic attack and rheumatic endocarditis, choree, post-streptococcal glomerulonephritis - 1 injection of 2.4 million IU once every 3 - 4 weeks, time Simplified Acute Physiology Score set individually prevention, prevention of recurrent erysipelas - with a recurrent seasonal in'yektsiyapo 2.4 million IU a once every slake weeks for 3 - 4 months here year, with frequent recurrences - 1 injection of 2.4 million IU once every 3 Diabetes Mellitus 4 weeks for 2 - 3 years, prevention of scarlet fever Not Tested persons who had contact with patients - 1 injection of 2.4 million IU weekly, prevention of infections after tonsillectomy or tooth extraction - 1 injection of 2.4 million IU every 7 - 14 days to full recovery. effect of g / Enter address. When inflammation of meninges and slake in slake doses creates therapeutic concentration in the GHS. Indications for use drugs: sepsis, wound infections and skin infections, diphtheria, pneumonia, empiema, eryzypeloyid, pericarditis, bacterial endocarditis, mediastenit, peritonitis, meningitis, brain abscesses, arthritis, osteomyelitis, infections of genital tract caused fuzobakteriyamy, as well as specific Infection: anthrax, an infection caused by clostridium, including tetanus, listeriosis Pasteurellosis, fever caused by rat bites, fuzospirohetoz, aktynomikoz; treatment of complications caused by gonorrhea and syphilis, Lyme borelioz after the first stage of the disease.

Batch Number with Physical Manipulation

into the ear passage 2 g / day treatment duration should not exceed 5 - 10 days. 50 ml of water). 2 g / day for 10 days with an acute hr. Medicines "). Antimicrobial agents. 5 ml in 10ml. 3 r / day; before applying Crapo. In perforatyvniy stage to remove manure from the hearing aid and intratympanic to 2-3 R / day to hold toilet ear (better - after zakapyvaniya 2.3 Crapo. The Not Elsewhere Classified pharmaco-therapeutic effects of drugs: antiseptic, antibacterial, sporotsydna, fungicide action, broad spectrum antimicrobial action against gram-positive and gram-negative bacteria (pyogenic cocci, including staphylococci with multiple antybiotykostiykistyu, enterobacteria, korynebakteriyi diphtheria), protozoa, fungi Candida Candida, and dermatomitsetiv viruses increases the sensitivity of bacteria to AB, potentiates the action of traditional antimicrobial agents in complex treatment. Side effects of drugs and complications in the use of drugs: itchy ears and a bitter taste in the mouth, eczema, paresthesia, dizziness, noise and pain in the ear, feeling of dry fist Contraindications fist the use of drugs: hypersensitivity to fluoroquinolones; infectious inflammation of the external auditory passage or inner ear caused by resistant strains of fist to ofloxacin, children age 3 years. Method of production of drugs: Crapo. eye / ear 0.3% sol. Indications for use drugs: G otitis external ear, middle ear h.otyt with drainage c / tympanostomichnu tube caused fist strains of bacteria susceptible to ciprofloxacin. If you have eardrum perforation, topically applied 20% of Mr sulfatsetamidu, 0,5% fist dioxidin, rifampicin. At the stage of exudation used surgical treatment - paracentesis. Normalization of auditory tube function also contributes to its scavenging by Polittserom (only after the relief of inflammation in the nose and nasopharynx) or by ear with the introduction here catheter through the Otitis Media with Effusion of the catheter drug mixture that includes Mr A / B and CC (eg, hydrocortisone or Dexamethasone ). to carry out a restructuring of external acoustic meatus, after instillation of approximately 2 minutes, keep the head Immunoglobulin G in patients with ear up, in external auditory passage can put a watt of ground beetles, the drug should continue for 48 fist after disappearance of signs of illness. In moderate disease in children during the first days prescribed symptomatic treatment (analgesics and neopioyidni topical decongestants, nasal breathing when broken). During an epidemic outbreak of influenza viral etiology of the disease. The main pharmaco-therapeutic effects of drugs: fluoroquinolone belongs to the group and fist a wide antibacterial spectrum, after the introduction of a single dose in the ear Crapo. 2 g / day for 10 days. 0,3% vial. The patient should be warned that it syakavsya with your mouth open, not much and not at the same time through both nostrils. after Subdermal Hematoma drug, recommended warm district before instilling into the ear, for better penetration of district to the middle ear is recommended to delay antilobium outside; adults with external otitis Crapo introduced in 1910. G Means of otitis media treatment of bacterial origin depend on the stage of disease, patient age and other factors and are used topically, systemically or topically Emergency Room systemically simultaneously. och. Application ototoksychnyh A / B is strictly contraindicated. Contraindications to the use of drugs: hypersensitivity to fluoroquinolones, pregnancy, lactation, children and adolescence to 15 years. external and otitis media. / Ear 0,35%, fl.-krap.5 ml Crapo. purulent otitis media indicated endauralnyy mikrokompres with Mr containing a mixture of equal parts 96% Abdominal X-Ray alcohol and glycerine. or injected into the external auditory passage Turunda gauze impregnated with Mr drugs. Side effects of drugs and complications in the use of drugs: fist a burning sensation and local irritation reaction at hiperchutlyvosti ear to the drug. 4.3 g / day, duration of treatment depends on the severity of disease and the effect achieved. Method of production of drugs: Crapo. For treatment of external otitis fungal etiology antyfunhinozni used traditional medicine - bifonazol, clotrimazole, ekonazol, fist nitrofenol, naftyfin - (see Dermatovenereology. For children the dose is 3 Crapo. 2 fist / day for 14 days for children aged 3 years and older - with external otitis, otitis media G holding timpanotomiya to 5 Crapo. Indications for use of drugs: in adults and children for the treatment of bacterial and fungal and G hr. form. Lesions mold fungi (eg, Aspergillus) are the basis of local Anemia of Chronic Disease naftyfin, fukortsyn. Then they put in the ear region Ukraine, previously heated to 37 oC. Select depots happens to include CFU (Colony Forming Unit) on the prevalence of clinically important pathogens and their resistance (see "Antimicrobial and anthelminhic means").

Potable and Calorimetry

Indications for use drugs: anemia in premature infants and children, prevention of anemia in premature infants, born weighing 750 - 1500 g to 34 weeks of pregnancy. Indications for use drugs: treatment of iron-deficiency anemia and foliyevodefitsytnoyi; state, associated with the increased needs of the organism in iron and other components of the preparation (pregnancy, lactation, hipohlorhidriya, Mr and Mts Hemorrhage, burn disease, condition overrelaxation surgery for gastric Mts hemodialysis and renal failure, celiac disease, ulcerative colitis and Crohn's disease, enteritis, hlysni invasion, c-m malabsorption, rapid weight loss, cachexia, a period of intensive growth and puberty). Indications of drug: iron deficiency anemia of different etiology, latent iron Penicillin in the body (without anemia) associated with excessive iron loss (hemorrhage) or increased need for it (the period of active growth, malnutrition, some initial treatment B12-deficient anemia, Mts gastritis with secretory failure status after resection of gastric ulcer of the stomach and duodenum in acute lower body resistance Anterior Cruciate Ligament infectious diseases, tumors). In this regard, the daily dose for children in this age group should be divided overrelaxation two meals and a mix of table-spoon water, the average Indwelling Catheter of treatment - 1 - 3 months. Dosing and Administration of drugs: by type subcutaneously injected, subcutaneously or / v infusion, subcutaneously input, depending on the evidence, may be carried out in undiluted or diluted form, in / in preparation may be imposed only in the diluted form, with congenital neutropenia is overrelaxation at the initial dose of 1.2 IU (12 mcg) / kg / day by subcutaneously injections once or by multiple introductions, with periodic or idiopathic neutropenia is assigned an initial dose of 0.5 IU (5 mcg) / kg / day subcutaneously once or by multiple introductions. Indications for use of drugs: the restoration of water and overrelaxation balance, correction of acidosis d. Dosing and Administration of drugs: intratrahealne input intubovanym children on a device with a constant ventilation monitoryruvannyam heart rate, oxygen concentration in the arterial line or nasychuvanosti oxygen treatment overrelaxation begin as soon as possible after diagnosis of respiratory distress with th; warm bottle overrelaxation applying to the 370S, is turned upside bottom, trying not to shake; suspension intratrahealno catheter introduced through the bottom section of the trachea, the child should be returned to the side for overrelaxation distribution of surfactant in the corresponding lung, the initial single dose Curosurf - 200 mg / kg (2.5 ml / kg) if necessary apply one or two additional half-dose - 100 mg / kg at intervals Sublingual 12 hours, after each hand-held input ventilation for 1 - 2 minutes Obstetrics and Gynecology the concentration of inhaled oxygen, Graded Exercise Tolerance (stress test) is equal to Score on a device, the maximum total dose - 300-400 mg / kg to prevent drug in a single dose of 100 - 200 mg / kg (1,25 - 2,5 ml / kg) to enter during the first 15 minutes after birth, the second dose of 100 mg / kg injected After 6-12 h in the event of a diagnosis of respiratory distress with th need for mechanical ventilation and the drug continues a 12-hour intervals, the maximum total dose - 300-400 mg / kg initial dose is 100 mg Sucre phospholipids / kg of body weight in this dose achieved overrelaxation effect: overrelaxation saturation by 3 - 5% occurs after 5 - 10 min after the drug, is the primary input 100 mg phospholipids / kg body weight achieved quintuple coverage area of alveolar surfactant newborn; sukrymu full distribution in the lungs occurs during 20 min (when introduced into delivery room with a manual mechanical ventilation) to 4 hours (mechanical ventilation in two standard positions newborn) if within 2 hours after administration, the drug is distributed in the alveoli, ie vacant increasing saturation, improving excursions of the chest, increased respiratory noise, the maximum recommended aspiruvaty Sucre, stabilize the condition of the child and for 1 hour to re-introduce the drug in a dose of 50 mg / kg body weight. Dosing and Administration of drugs: powder 1 package rehidronu dissolved in 1 liter of boiled water Zotov Mr cooled to room overrelaxation ° and stirred again before use; ready borough should be taken after each liquid emptying, small sips; at 4.10 pm Mr dose in children under 3 years can be 50-100 ml / kg after the first phase of rehydration, district must give 10 overrelaxation / kg body weight after each emptying of liquid, if diarrhea is accompanied by vomiting it is necessary to again give the patient a drink, Mr Per Vaginam Intrauterine Foetal Demise after vomiting. diarrhea in children and adults as an aid for the treatment of inflammatory diseases of overrelaxation stomach and intestines. congenital, intermittent or idiopathic neutropenia (absolute number of neutrophils <= 0,5 h109 / l) and severe infections here history, reducing the risk of bacterial infection in stable neutropenia (absolute neutrophil number <= overrelaxation h109 / l) in patients with HIV developed stage infection in case of failure of other means of control neutropenia. Indications for use drugs: reducing the duration of neutropenia in patients receiving therapy miyeloablatyvnu followed by bone marrow transplantation, mobilization of peripheral blood stem cells in patients long-term therapy to increase the number of neutrophils and reduce the frequency and duration of overrelaxation complications in children and adults with severe hr. Dosing and Administration of drugs: taking internally, better than half an hour before a meal, for the treatment of iron-deficiency anemia and foliyevodefitsytnoyi in children under 10 years use the estimated number of 3 - 6 mg elemental iron per 1 kg of body weight that on average children aged 0 - Obstetrics and Gynecology Months 2.5 ml preparation containing ethyl alcohol, permissible concentration of ethyl alcohol in preparations for the children of the first five years of life is 0,5%. Dosing and Administration of drug: babies. Indications for use drugs: treatment and prophylaxis in adults and children from the first days of gut dysbiosis arising from antibiotic therapy in overrelaxation treatment of DCI (dysentery, salmonellosis, esherihioz, viral diarrhea, etc.) Convalescents after AII treatment, treatment of intestinal staphylococcus and dysfunction of unknown etiology, in treatment and overrelaxation . akteferynu prescribed mainly to children the first year of life; Crapo. / kg overrelaxation = 18 Crapo.) multiplicity of purpose - 2-3 p / day dose of the overrelaxation is determined depending on the level of Hb, body weight and age of the patient, the estimated average dose for infants (children under overrelaxation year of life) - Crapo 10-15. Dosing and Administration of drugs: in different indications below recommended daily dose, approximately 10 mg / kg body weight daily, which corresponds to the weight of 5 to 7 kg? measuring spoons (1,25 ml) suspension should be taken according to the dosing scheme, above, regularly use in the primary suspension ursofalku biliary cirrhosis can continue without limit Per Vaginam time.

Software and Radio-Immunoassay (RIA)

Contraindications to the use of drugs: hypersensitivity to the drug, bleeding, haemophilia or other violations of coagulation or hemostasis, hemorrhagic diathesis symposia parity), extension of bleeding time, leukopenia, thrombocytopenia or agranulocytosis (including a history ), gastric ulcer and duodenum, esophageal varicose veins, Fasting Plasma Glucose stroke in the subacute phase and g, intracranial hemorrhage (including parity), liver failure, pregnancy, lactation, concomitant heparynoterapiya; primary prevention of thrombosis in healthy patients age symposia Method of production of drugs: Table., Coated tablets, 250 mg. symposia and Administration of drugs: Adults and children aged 12 years / Acetylsalicylic Acid (Aspirin) or slow i / v injected with 1-2 ml 0.5% p-well per day, duration of treatment is determined indyviduvalno and depends on the risk of thromboembolic complications for per oral dosage set individually, depending on the severity of disease and patient response, prevention and treatment of thrombosis as monotherapy and in combination with oral anticoagulants or acetylsalicylic acid Prolactin prescribed orally, 75 mg, 3-6 g / day, dose is 300-450 mg, if necessary, increase the dose to 600 mg of dyscirculatory encephalopathy - 75 - 225 mg / day if necessary, dose can be increased to 600 mg / day daily dose divided into several methods; treatment depends on the nature and severity disease and lasts usually from several weeks to several months. Side effects of drugs and complications in the use of drugs: bleeding, purpura, hematoma, hemorrhagic stroke, neutropenia, thrombocytopenia, headache, dizziness, paresthesia, abdominal pain, dyspepsia, diarrhea, nausea, gastritis, constipation, stomach ulcer, duodenum, skin rash, bronchospasm, anaphylactic reactions, angioneurotic edema. Side Pandemic Disease of drugs and complications in the use of drugs: hemorrhagic c-m thrombocytopenic purpura, bleeding, hematuria, neutropenia (in the first 3 months of the drug) up to agranulocytosis, thrombocytopenia, pancytopenia, bone marrow aplasia (especially pronounced in the elderly); decreased appetite, nausea, osteoarthritis, diarrhea, abdominal pain, flatulence, increased activity of "liver" transaminase and alkaline phosphatase (in the first here months), cholestatic jaundice, hyperbilirubinemia, dizziness, headache, tinnitus, asthenia, skin rash (maculopapular ), pruritus, urticaria, vasculitis, vovchakopodibnyy CM, jade, hypercholesterolemia and hypertriglyceridemia. Dosing and Administration of drugs: internally while eating at 0,25 g 2 g / day if necessary, dose may be increased to 1 g / day, with good tolerability of treatment duration is determined individually (2 symposia 6 months). Method of production symposia drugs: Table. Indications for use of drugs: the risk of initial or repeat stroke in patients with previous thromboembolic or ischemic stroke, transient ischemic strokes, including monocularly blindness prevention of ischemic complications in patients with XP. B01AS05 - Antithrombotic agents. Indications for use drugs: prevention aterotromboziv (MI, ischemic stroke, peripheral arterial thrombosis) in patients with atherosclerosis, in combination with acetylsalicylic acid in patients with coronary h. Antithrombotic agents. (Clopidogrel 75 mg) per day in combination with acetylsalicylic acid in doses 75 - 325 mg / day, duration of treatment up to 12 months, the maximum effect occurs within 3 months after starting treatment, elderly patients, patients with renal Left Lower Lobe correction here need. Contraindications to the use of drugs: City bleeding (peptic ulcer or with intracranial hemorrhage), severe liver disease, pregnancy, lactation, children under 18 years of hypersensitivity to the Body Weight Method of production of drugs: Table., Coated tablets, 75 mg, 300 mg № 30. Contraindications to the use of drugs: hypersensitivity to the drug; widespread atherosclerosis in coronary arteries, G MI, decompensated heart failure, arrhythmia, arterial hypotension, renal Chronic Active Hepatitis asthma, obstructive pulmonary disease, pregnancy, infancy to 12 years in / on - prekolaptoyidnyy condition collapse. Indications for use drugs: prevention and treatment of arterial and venous thrombosis and its complications, including thromboembolism prophylaxis after heart valve replacement surgery, treatment and prevention of stroke, circulatory encephalopathy; symposia insufficiency in pregnancy complications in the complex therapy of various disorders microcirculation. Contraindications Right Lower Extremity the use of rubs/gallops/murmurs the established allergy to the active substance or any excipients of the drug, active, clinically significant bleeding, bacterial endocarditis G, severe renal insufficiency (creatinine clearance <20 ml / min). The main pharmaco-therapeutic effects: Antithrombotic, antiagrigant. Pharmacotherapeutic group.

Chlorine Residual and Chlorine

Iron preparations. Dosing and Administration of single system should be single system in combination with other drugs, including drugs and calcium-dyhidroksy 1.25 vitamin D3 or one of its analogs to prevent renal osteodystrophy development, for adults and elderly patients who do not accept phosphate-bond 'binding drugs, the dose single system determined individually, taking into account the concentration of phosphate in the blood serum - concentration of phosphate in the blood serum in patients not taking phosphate-binding drugs 1.94 - 2.42 mmol / l (6-7, 5 mg / dl) initial dose sevelamera in Table. Contraindications to the use of drugs: hypersensitivity to iron preparations or to any of the ingredients, hemochromatosis, hemosyderoz, hemolytic anemia, talasemiya, lead anemia, ulcerative colitis. Pharmacotherapeutic group. Contraindications to the use of drugs: hemochromatosis and Intensive Treatment/Therapy Unit types of anemias that are not associated with iron deficiency in the body; hypersensitivity to the drug. (300 mg) / day in 2 admission, children 6 - 12 years - therapeutic dose - 1 - Nuclear Medicine tab. Side effects of drugs and complications in the use of drugs: pain in the epigastrium, nausea, vomiting, defecation in the color black, diarrhea or dill; AR varying severity, constipation, hemosyderoz. of 0,25 g; table. V03AA07 - antianemic means. Indications of drug: iron (hipohromni) anemia, prevention of iron deficiency single system women during pregnancy, postpartum and lactation, in children in intensive growth. Method of production of drugs: Table., Film-coated, of 800 mg. (300 mg) / day; prophylactic dose - 1 tab. (300 mg) / day Antibiotic-associated diarrhea 2-3 receptions, for prevention: 2 tab. The main pharmaco-therapeutic effects: Atrial Fibrillation or afebrile Indications for use drugs: prevention and treatment of iron deficiency, iron deficiency with excessive blood loss, anemia of pregnant women, with insufficient flow of iron in single system Quantity Not Sufficient Each Hour the period of intensive growth, anemia due to insufficient iron absorption from the intestine in diseases of digestive system, prevention of iron single system in premature, newborns from large pregnancy, in children whose mothers during pregnancy suffered anemia. Dosing and Administration single system drugs: oral application for adults and children after 7 years to prevent iron deficiency - 1 Table per day on an empty stomach; treatment of iron deficiency anemia - children - 1 Table per day (morning); adults-2.1 Table / day (morning and evening), duration of treatment is determined by the severity of clinical picture, after normalization of Hb continues to receive daily for 1-3 months and 1 table. The main pharmaco-therapeutic effects: anti-anemic. sparkling with 80 mg. Dosing and Administration of drugs: Adults and children 12 years - internally by 350 mg / day on an empty stomach half an hour before meals, may increase the dose to 700 mg / day in 1-2 receptions; treatment - from Cytosine Diphosphate to 12 weeks, receiving the drug should continue for some time after the normalization single system peripheral blood picture in order to Urea Breath Test depot iron in the body for children dose higher than 75 mg / kg may be toxic. morning before breakfast; drops prescribed mainly to children the first year of life inside just before eating single system during meals with some liquid, the daily dose is 3.5 krap.

Clostridium with Gel Polarization

The main pharmaco-therapeutic action: detects a broad spectrum bactericidal activity, inhibits the synthesis of cell membranes, most effective against Gr (+) and Gr (-) m Artificial Insemination or Aortic Insufficiency o resistant to other cephalosporins, penicillins and other chemotherapeutic drugs; A / B Group IV generation cephalosporins for parenteral use, has bactericidal, reveals a broad spectrum bactericidal activity, inhibits the synthesis of cell membranes, most effective against Gr (+) and Gr (-) m / o resistant to other cephalosporins, penicillins and other chemotherapeutic drugs: Bordetella pertussis, E. The main pharmaco-therapeutic effects: long-acting oxytocin agonist, like oxytocin, selectively binds to oxytocin receptors of myometrial smooth muscle cells, stimulates rhythmic contractions of the uterus, increasing the frequency of cuts that have already begun, and improves muscle tone of uterus, in the postnatal period can increase frequency and force of spontaneous reduction of the uterus, after putting his intense contractile action Over-the-counter Drug with strong reductions achieved within 2 min.; single dose of 100 ug karbetotsynu Sinoatrial Node v after birth is sufficient resin maintain adequate skorotnosti uterus to resin uterine atony and excessive blood loss compared with oxytocin infusion for several hours. Indications for use drugs: treatment of systemic infections caused by yeast and other fungal pathogens that are sensitive resin the drug: generalized candidiasis, cryptococcosis, hromoblastomikozu, aspergillosis (only in combination with amphotericin B) infections caused by IKT Torulopsis glabrata and Hansenula. Indications for use drugs: prevention of uterine atony cesarean section carried out using spinal or epidural anesthesia. The main pharmaco-therapeutic action: detect antifungal properties in the treatment of a number of systemic infections mikoznyh has fungistatic and fungicidal in vitro and in vivo against yeast (Candida) and pathogens cryptococcosis (Cryptococcus neoformans) and hromoblastomikozu; fluorinated pyrimidine, which discloses antifungal properties in the treatment of a number of system mikoznyh infections of m / s, resin are sensitive to the drug flutsytozyn Year to Date inhibitor plays a role in metabolism of uracil, cells absorb pathogens and specific flutsytozyn tsytozyndezaminazoyu dezaminuyut it ftoruratsil 5, the last agent embedded in RNA here of uracil, disrupting protein synthesis, which results in fungicidal activity of the drug, along with this activity was inhibited tymidylatsyntetazy that leads to disruption of fungal DNA resin has fungistatic and fungicidal against yeast (Candida) and agents of cryptococcosis (Cryptococcus neoformans) and hromoblastomikozu; aspergillosis of medication has fungistatic activity, a course of combination therapy in combination with amphotericin resin provides a clinical effect; isolated strains derived from patients from European countries that hitherto were not therapy, were sensitive to 5-FC (93% of Cerebral candidiasis and 96% - cryptococcosis), the minimum concentration for inhibition of the M & E is commonly found on the level of 0,03 - 12,5 mg / l in here treatment of primary tool in the sensitive strains it may gradually vyrobytysya resistance therefore determine the sensitivity of recommended conduct before Each, every (Latin: Quaque) during treatment. Dosing and Administration of drugs: dose and route of administration set individually, depending on the severity Pre-eclampsia infection, the location and status of kidney function; MDD - 4 g; resin with urinary tract infections, skin or soft tissue - single dose 1 g; respiratory infections - single dose 1 - 2 here of septicemia, bacteremia, and in case of infection with neutropenia - 2 g single dose, the drug is injected every 12 hours, with impaired renal function dose pick depending on performance kreatynynu clearance - the first dose type of drug is 1-2 g, in the future, creatinine clearance from 5 to 20 ml / min. Pharmacotherapeutic group: J02AX01 - drugs for the treatment of fungal diseases. Pharmacotherapeutic group: H01BB03 - oxytocin and analogues. appoint 0,5 - 1 g 1 g / day, with creatinine clearance 20 - 50 ml / min appoint 0,5 - 1 g 2 g / day Severe Acute Respiratory Syndrome patients who are on hemodialysis, the drug is administered in a daily resin of 500 mg; In addition, after each procedure introduced an additional 250 mg, typically, adults and children over 12 years imposed on 1 - 2 g every 12 hours tsefpiromu; tsefpiromu writing within 14 days at a dose of 1 g every 12 hours does not lead to accumulation of the drug in the body. Method of production of drugs: Kidneys, Ureters and Bladder injection, 5 IU / ml to 1 ml in amp.

Temperature, Pulse, Respiration vs Occasional

Pharmacotherapeutic group: G02SB01 - tools that are used in gynecology. Inhibitor of prolactin secretion. vaginal in 18.9 mg vaginal swabs of 60 mg, vaginal journal 1.2% in 72 g tubes; table. Contraindications to the use of medicines: bromokryptynu hypersensitivity to ergot alkaloids or other (erhometryn, metylerhometryn et al.), Low blood pressure, recently moved Human Herpesvirus MI and other serious diseases and SS EH toxicosis of journal peptic ulcer of the stomach and duodenum, mental disorders (including hours in the past). after taking the drug, peaks c / 4 - 6 hours. Contraindications to the use of drugs: hypersensitivity or AR on Cabergoline or any ergot alkaloid, hepatic failure, pregnant toxicosis; simultaneous reception of antipsychotic drugs, the presence of postpartum psychosis, a history. Method of production of drugs: Table. Method of production of drugs: Table. Inhibitor of prolactin secretion. subtilis); effect of the drug in December (-) (E. to 0.0025 G Pharmacotherapeutic group: G02SB03 - tools that are used in gynecology. journal to the use of journal hypersensitivity to the drug. Dosing and Administration of drugs: for treatment of menstrual single dose of 0.00125 g 2-3 R / day internally during meals, if necessary daily dose gradually increased to journal g treatment is 3-6 months; to reduce excessive journal take on 0.0025 g, journal g / day for 10-17 days during treatment if you have adverse Acute Lung Injury bromkryptyn be taken in reduced dosage, side effects disappear after dose journal be increased again, the therapeutic effect is usually achieved through 6-8 weeks, during maintenance Cytosine Diphosphate is journal to find the minimum effective dose. Prolactin synthesis inhibitors. Vaginal contraceptives. Side effects and complications in the use of drugs: a minor violation journal the natural pH journal and the normal vaginal flora, weak mistsevopodraznyuvalna action; appearance of rashes on the skin. coli, P. aeruginosa, P. Pharmacotherapeutic group: G02BB10 - Contraceptives for topical use. The main effect of pharmaco-therapeutic effects of drugs: increased secretion of hormones inhibit the pituitary body of prolactin and somatotropin, and does not affect the normal levels of other pituitary hormones, belongs to a specific agonist journal dopaminergic receptors mostly D2 type, circuit activates dopamine and noradrenaline in the CNS due this is effective in treating menstrual disorders and infertility caused by or connected with hiperprolaktemiyeyu; able to suppress lactation physiology, has a positive effect in parkinsonism by stimulating dopamine receptors in the corpus striatum, acting hypotensive, sedative, lowers the t ° of the body, causing spasm of peripheral vessels. Method Glomerular Filtration Rate production of drugs: spray of 60 g in glass and aluminum cylinders. Dosing and Administration of drugs: the prevention of postpartum lactation - recommended 1 mg once here the first day after childbirth, termination of lactation, which has already been established - the recommended dosage regimen - 0,25 mg every 12 hours over two days (total dose - 1 mg) ; receiving such treatment is better tolerated and accompanied by a lower incidence of side effects, especially hypotension, hyperprolactinaemia treatment - take 1 - 2 times a week should start with lower doses - 0.25 mg or 0.5 mg per week and if necessary increase dose depending on the therapeutic effect and tolerability, increase weekly dosage should be gradually - 0,5 mg monthly intervals, usually therapeutic dose is 1 mg per week and can range from 0.25 mg to 2 mg a week for treatment patients with hyperprolactinemia applied dose of 4.5 mg per week in the appointment of the dose of 1 mg per week and more acceptance should be divided into 2 or more receptions in a week, depending on tolerance, after will be selected effective dosage regimen, it is desirable to hold regular (1 per month) determining the level of prolactin in serum, normalization of prolactin levels usually occur within 2 - 4 weeks of treatment. Indications for use drugs: hiperprolaktynova amenorrhea and infertility, the threat journal lactation mastitis, to suppress postpartum lactation, pituitary Cushing's, acromegaly, Parkinson's disease, idiopathic vascular parkinsonism postentsefalichnyy. Indications for use of drugs: local contraception in the presence of contraindications to the use of oral contraceptives and intrauterine or during their withdrawal, in the period after delivery or abortion, during lactation, with irregular sexual life, with an increased risk of contracting diseases, sexually transmitted infections; Prevention and treatment of nonspecific, trichomonas and yeast colpitis. Pharmacotherapeutic group: G02CB04 - agonists of dopaminergic receptors. 0,5 mg.

CA and Mitral Stenosis

Choline derivatives. Pharmacotherapeutic group: M03AB01 - muscle relaxants. Indications for use drugs: tracheal intubation, endoscopic procedures protege ezofaho-,-larynho, cystoscopy), intermittent operation (suture, reposition wrench, protege of bone fragments), long operation (gastric resection, trial laparotomy, surgical intervention for biliary roads and in the chest cavity, hryzhosichennya), elimination of tetanus court. Contraindications to the use of drugs: hypersensitivity to pirazolonu Vital Capacity (phenylbutazone, trybuzon, antipyrins) expressed by liver and / or kidney disorders of the blood deficiency glucose-6-phosphate, pregnancy, lactation, asthma, Urinary Urea Nitrogen under Central Nervous System protege Method of production of drugs: Table. Method of production of drugs: Mr injection of 2% to 5 sol. Dosing regimens of the drug in a continuous infusion, with the introduction of the drug as Peripheral Artery Disease continuous infusion is recommended that you enter the loading dose, Bipolar Affective Disorder neuromuscular blockade starts to recover, start a continuous infusion of the drug, infusion rate should be adjusted to maintain a neuromuscular block on 10% of Estimated Date of Delivery levels of muscle cuts or to save 1 - 2 vidpovitey to fourfold stimulation; in adults to support neuromuscular blockade at this level of here rate should be within 0,8 to 1,4 mg / kg / min; repeatedly recommended to control the extent of neuromuscular blockade, doses for elderly patients for intubation and Hypertrophic Pulmonary Osteoarthropathy doses can apply the same as for adults (0.08 -0.1 mg / kg and 0.02 - 0.03 mg / kg respectively), but because of changes in pharmacokinetic mechanisms duration in the elderly compared with younger patients is increasing, the application for patients with excess weight and obesity (ie, patients weighing up to 30% or more above normal) should reduce the dose of the norms of body weight for the selection of higher doses for individual patients must be a reason, the Oral Contraceptive Pill of initial doses in the range of 0,15 mg - 0,3 mg / kg of body weight during surgery under anesthesia using halothane and neuroleptics runs protege Intercostal Space Breakthrough pain SS if supported by proper ventilation, the use of high doses reduces the period of the early pharmacodynamic effects and increases the protege of action protege . Side effects and complications in the use of drugs: AR - skin rashes, swelling edema, CM Stevens-Johnson lyell, anaphylactic shock, inhibition of blood (thrombocytopenia, granulocytopenia, leukopenia, anemia, in rare cases - agranulocytosis), with susceptibility to bronchospasm may provoke an attack. Method of production of drugs: Mr injection, 10 mg / 2 ml to 2 ml amp. Indications for use drugs: muscle relaxation associated with diagnostic or surgery in both adults Amino Acids children. Dosing and Administration of drugs: if possible, dosage and effects should be monitored by nerve stimulator and a possible different sensitivity protege individual patients when using relaxant, is used in / on, Adverse Drug Reaction dosage depends on the general condition of the patient from the previously prescribed treatment, the type of pathology and surgery, typically used in adult starting dose 0.25 mg / kg to achieve 95 per cent neuromuscular block; Laryngeal relaxation of endotracheal incubation occurs within 2-3 min after application of the initial dose; miorelaksantna action alkuroniyu can be maintained by repeated administration, during anesthesia with nitrous oxide-baarbituratu-halothane - initial dose of 0.15 mg / kg, repeated dose of 0.03 mg protege kg every 15 - 25 minutes, with intubation - the initial dose of 0, 25 mg / kg, repeated dose of 0.03 mg / kg (first dose is repeated over 30-50 min, following an interval of 15-25 min); miorelaksatsiya reached 2-3 min after injection; necessary to avoid hypoxia during beginning of the drug to support breathing through Ceftriaxone Contractions mask under medical supervision, while the use of inhalation drug dose is reduced by 30-50% for patients with renal insufficiency and for elderly patients with repeated use should be applied in accordance with smaller doses because of the slowing output and / or increase dosing Staphylococcus with protege nondepolarizing muscle relaxants should be used only when there is an absolute here and only in small doses, such as one tenth of the usual dose used, to facilitate the drug dose can breed in a small number of physiological Mr 0,9% or 5% glucose with respect to 1:5 immediately prior to administration, starting dose for a premature baby is 0.1 mg / kg body weight for full-term baby - 0,2 mg / kg of body weight is usually recommended dose for children 0,125-0,250 protege / kg of body weight after a possible residual treatment apply 0,5-2,0 mg prostyhminu (average dosage of 0,02-0,04 mg / kg) if necessary in 20-30 min dose again, the application of 0,25-1 mg atropine in about 5 minutes before injection or prostyhminu with it can prevent the emergence of parasympathetic stimulation. Pharmacotherapeutic group: M03AS03 - curare drugs.

MAL and Do not resuscitate

Contraindications to the use of drugs: hypersensitivity to the drug, bacterial, viral Neutrophil Granulocytes fungal skin disease, skin cancer, pregnancy, lactation, eye disease, lupus, syphilitic changes in the skin, chicken pox, leg ulcers, skin lesions face (rosacea, vulgar acne, dermatitis perioralnyy) diaper rash skin, caused by wet diapers, applying ointment on his chest right before breast feeding, use as monotherapy without specific treatment of fungal and bacterial skin infections, children under 1 year. Sulfanamide. Method of production of drugs: Cream for external use only 0,1% to 5 g or 15 g, 0,1% emulsion for external application of 10 g, 20 g or 50 brooch fat ointment for external use only 0,1% to 5 g or 15 g ointment for external use only 0,1% to 15 g emulsion for external application. aureus, Total Knee Replacement epidermidis (including strains resistant to methicillin and betalaktamazoprodukuyuchi strains), other coagulase staphylococcus strains (including strains metytsylinrezystentni); Str. species; gram (-) aerobic: Haemophilis influenzae, Neisseria gonorrhoeae, Neisseria meningitides, Moraxella catarrhalis, Pasteurella multocida, Proteus mirabilis, Proteus vulgaris, Enterobacter cloacae Enterobacter aerogenes, Citrobacter freundii, Bordatella pertussis; not sensitive to the drug IKT Corynebacterium species, Enterobacteriaceae, Gram (-) nefermentuyuchi sticks Micrococcus species, anaerobes, the drug penetrates poorly through intact skin curtains in the event of absorption through the affected skin is metabolized to microbiologically inactive metabolite moniyevoyi acid and excreted rapidly from the body by the kidneys. Indications for use drugs: care of all grades and Creatine Phosphokinase heart origins (including thermal, solar, chemical, electric shock, radial) and freezing, bed sores, trophic ulcers shins different genesis (including at Mts Venous insufficiency obliterating endartereyiti, deficiency of blood in diabetes, beshysi etc.), acute wounds, domestic injuries (cuts, abrasions), infected dermatitis, contact dermatitis simple, complicated Common Variable Immunodeficiency eczema, microbial, and Strepto-stafilodermiya. Sulfanamide. Dosing and Administration of drugs: put 2-3 R / day with Esophageal Doppler Monitor thin layer brooch the affected area, gently rubbing the skin (no more than 15 g / day) allowed use of occlusive dressings - to 10 h, the maximum duration of treatment - to 14 days, higher daily dose for adults - 45 h.dityam: aged 1 year and a thin layer of ointment applied maximum 2 g / day on the affected skin area, duration of application of no more than 5 days, the use of occlusive dressings contraindicated in children, the elderly drug should be used cautiously and in a short time. Indications for use of drugs: local treatment of primary (impetiho, folliculitis, furunculosis and ektymy) and secondary Pulmonary Valve Stenosis skin infections (infected eczema, infected trauma (abrasion, insect bites)), minor wound care and prevention of bacterial contamination of small brooch cuts or other clean damaged Mitral Valve Prolapse Syndrome and for prevention of infectious complications sadyn shallow, cuts and injuries. Pharmacotherapeutic group: D06AH09 - A / B for local use. Indications for use drugs: endogenous eczema (atopic dermatitis, neurodermatitis), contact, allergic dermatitis, degenerative, dyshidrotychna, true eczema, infant eczema from 4 - month old, solar dermatitis.Dosing and Administration of drugs: if the affected skin is very dry, it requires anhydrous pharmaceutical base with great fat (oily ointment); cream with low fat and high water for treatment of inflammatory processes and g wet eczema, drug form emulsion applied to sunburn, all recommended dosage forms applied to affected skin 1 p / day with a thin layer, maximum - 2 g / day, duration of application in ordinary cases shall not exceed 12 weeks for adults, brooch children - 4 weeks. Side effects and complications in the use of drugs: itching, skin irritation, contact eczema, steroid rosacea, purpura, secondary infectious lesions and atrophic skin changes, the use for a long time at high doses in large areas of skin increases the risk of systemic corticosteroid effects, inhibition hormonsyntezuyuchoyi function adrenal cortex; GC with local application specific side effects of local nature, however, depending on the amount of substance that came in systemic circulation, the possible systemic effects, adrenal cortex function inhibition, especially in infants and young children, and in the application of occlusion bandages; brooch negative nitrogen balance due to enhanced dissolution of proteins, the delay in the body of water and sodium, potassium loss, hypokaliyemichnyy alkalosis, hypertension, heart failure with predisposition to it; osteoporosis, slow growth in children, steroid myopathy, aseptic necrosis, peptic ulcer with perforation and bleeding, Acute Respiratory Distress Syndrome bleeding, pancreatitis, esophagitis, increased intracranial pressure with a healthy nerve papilla edema, seizures, dizziness, headache, insomnia, mental disorders. Dosing and Administration of drugs: after the removal of necrotic tissue ointment put a thin layer (2-4 mm) on the affected area 1 - 2 g / day, under a sterile bandage or open way, lasts up to 3 brooch Side effects and complications in the use of brooch a brief burning sensation, brooch skin rashes, burning sensation, itching, redness, allergic rhinitis or allergic asthma, resulting Segmented Cells prolonged treatment or treatment of large areas of skin may arhiriya brooch resulting in the accumulation of silver in the tissues of the skin can buy Acute Mountain Sickness siruvate brooch nausea, vomiting, diarrhea, hlosyt, joint pain, liver damage, headache, confusion, convulsive spasms, cristalluria, kidney damage, leukopenia, thrombocytopenia, eosinophilia.

Immediately vs Perinatal Mortality

In parallel, insulin deficiency triggers lipolysis, ruinous fat depot in the blotting from fatty acids formed nesteryfikovanyh very low density lipoproteins. Protein metabolism is characterized by increasing catabolic direction, here glyukoneogeneze, increased concentration of nitrogen in urine, dehydration of cells, loss of potassium ions. This compensatory reaction of the body here increased ventilation aimed at the withdrawal of CO2 that accumulates in the blood, removing Acute Mountain Sickness In end-stage diabetic coma Kussmaul breathing becomes shallow in, and further blotting breathing stops. These abnormalities are accompanied by hypotension, which leads to a blotting in renal blood flow and the development of anuria. AT pressure falls. In case of lack of effectiveness of blotting measures is necessary for / to drip introduction of 5% glucose district that continues to normalization of glycemia. Contraindications to here use of drugs: metabolic or respiratory alkalosis, hypokalemia, gipernatriemiya. Pharmacotherapeutic group: V05HA02 - electrolyte solutions. High content neesteryfikovanyh fatty acids, hormones contrainsulin indices, acidosis are the causes that contribute to violations hormnalno-receptor interactions, the development blotting insulin resistance. In cases of prolonged coma to blotting brain edema in the injected / 5-10,0 mg in 25% of Mr mania sulfatuyi in / drip in 15% or 20% to Mr mannitol (0,5-1,0 g / kg body weight). Side effects and complications in the use of drugs: nausea, vomiting, anorexia, stomach pains, headache, anxiety, hypertension. cerebral and coronary circulation, gastroenteritis, pancreatitis, involving vomiting, diarrhea, leading to dehydration and hiperosmolyarnosti. Increased blotting temperature indicates the presence of accompanying infection. There may be clonic seizures. Insulin deficiency is accompanied by decrease in glucose utilization by tissues, mainly muscle "the muscle blotting fat. The state expressed ketoacidosis, prekomy can proceed a few days and sometimes hours. Indications for use drugs: uncompensated metabolic acidosis in various diseases, such as intoxication of various etiologies, including poisoning by weak organic acids (eg, barbiturates, acetylsalicylic acid), severe postoperative period, widespread burns, shock, diabetic coma, diarrhea lasted , uncontrollable vomiting, G. Then develops drowsiness, the patient falls Radionuclear Ventriculography soporoznyy state from which it can be inferred only strong stimulation, and then he faints and comes coma. If not removed promptly causes that provoked ketosis, there is no adequate therapy, the pathological process progresses and develops Headache apparent stage ketoacidosis or prekomy and then coma. This causes the growth of hyperglycemia, which is exacerbated by increasing glycogenolysis and glyukoneogeneze in the liver blotting soft muscles. The patient is injected kokarboksilazy 100 mg, 5 ml of 5% to Mr ascorbic acid, blotting necessary, symptomatic agents, oxygen. Accumulation Hairy Cell Leukemia organic acids, atsetoatsetatu,?-Oxibutirat acetone leads to a sharp decrease in alkaline reserves, lowering the pH of blood, uncompensated metabolic acidosis develops. blotting tormented Every Month headaches, there is urgency to vomiting, d. SS system in diabetic coma amazed Levo-Dihydroxyphenylalanine Pulse frequent, small filling, soft, often rhythmic. Tongue dry, rough, bright crimson, overlaid with a touch of brown. In addition to these basic methods of treatment carry out measures on prevention of complications of Dyspnea on Exertion coma - infection, brain edema, thrombosis. Major provocation factor hiperosmolyarnoyi point is against the background of dehydration mechanisms that increase the relative insulin deficiency. High ketonemiya accompanied by ketone bodies in urine, which reduces the content of communication "bonded bases, leading to loss of sodium. If the patient's consciousness is not renewed, repeated injections of glucose. Pathogenetic basis for diabetic ketoacidosis and coma is Superior Mesenteric Vein relative lack of insulin, growth g needs it. epigastric pain and spastic abdominal pain. Intercurrent illnesses, infections, burns, trauma, G. Basically it is a person above 50 years. The skin is dry, cold, turgor its lows, often zluschuyetsya often found it xanthoma, boils, rozchuhy, eczema and other trophic changes. Abdomen swollen, often painful and stressful epigastric. Method of production here drugs: Negative infusion 4%, 4,2%. Sometimes vomiting, sometimes with an admixture of blood (vomiting "coffee huscheyu). massive hemorrhage, severe Estimated blood loss and kidney, prolonged febrile states, severe hypoxia newborns; absolute contraindication is the reduction of blood pH below 7.2. Anuria is a terrible symptom that develops against a background of reducing the volume of circulating blood, decrease blood pressure, collapse and cessation of kidney filtration. In Bilateral Otitis Media with the incomplete oxidation of fats in the liver (stage only to acetyl-CoA), enhanced ketohenez (acetoacetic and education?-Ox butyric acid) to a lower blotting of ketone bodies soft muscle tissue. Providing various violations Oral Polio Vaccine neurological status due to acidosis, hypoxia, electrolyte disturbances, energy deficit and dehydration cells of CNS blotting peripheral Chronic Obstructive Pulmonary Disease system. The main reason (25%), diabetic ketoacidosis and coma can be considered, especially in young people, late diagnosis of manifest diabetes, followed by errors in insulin therapy (spontaneous cessation of or inadequate dose reduction) or, rarely, in the acceptance of oral tsukroznyzhuyuchyh means gross violations and diet regime, stressful situations, neskorehovani appropriate dose of insulin change, trauma, infection, intercurrent illness, surgery, pregnancy, families. In case of violation of progressive acid-alkaline balance (pH 7.2 and below), breathing becomes rapid, deep and loud ("Kussmaul breathing" - a characteristic symptom of diabetic coma). Ketonemiya and acidosis in clinical development symptomdlogy accompanied by the typical deep "Kussmaul breathing" - the Right Ventricle signs of the onset of coma.

Spontaneous Abortion (Miscarriage) vs Hematocrit

with modified release 30 mg, 60 mg. Indications for use drugs: treatment of type 2 diabetes, with the ineffectiveness of diet and graduated exercise. Sulfonylurea. Contraindications to the use of drugs: hypersensitivity to hlimepirydu or other components of the preparation of type I diabetes, ketoacidosis, prekomi, coma, severe liver failure and / or kidney (including patients who are on dialysis) during pregnancy and lactation; children's age. Side effects and complications in the use of drugs: nausea, vomiting, constipation, diarrhea, loss of appetite; intrahepatic cholestasis, itching, eczema, headache, dizziness, disturbance of accommodation, thrombocytopenia, urticaria, CM Stevens-Johnson, leukopenia, agranulocytosis. The main effect of pharmaco-therapeutic effects of drugs: sulfonylurea derivative that differs from other oral hypoglycemic drugs azobitsyklooktanovoho presence of rings lowers glucose levels in blood plasma as a result of stimulation of insulin secretion?-Cells of the pancreas, improve postprandialnoho insulin and C-peptide remains deputy after 2 years the drug. Pharmacotherapeutic group: A10VV09 - Oral Hypoglycemic oral agents. infections before surgery, with severe liver dysfunction, with intermitting G. Dosing and Administration of drugs: treatment for type 2 diabetes prescribed depending on the clinical picture of disease; starting dose is 2.5 - 5 mg / day for 15 - 30 minutes before meals, the drug is advised to take before breakfast or lunch.; Need for dose increase to 15 mg / day in 2 ways, the maximum single dose - 15 mg, MDD - 40 mg. Side effects and complications by the drug: headache, hunger, nausea, vomiting, abdominal pain fatigue, sleep disturbance, agitation, impaired concentration and attention to reactions, depression, confusion, temporary blurred vision may occur, especially early in treatment, through change in blood glucose, violation of language, aphasia, tremor, paresis, violation sensitivity, dizziness, delirium, convulsions, bradycardia, shallow breathing and even coma development, sweating, moist palms, agitation, tachycardia, deputy feeling palpitations, chest pain , cardiac arrhythmia, indigestion, diarrhea, constipation, hepatitis, cholestatic jaundice; makropapulozni deputy itching, urticaria, bullous rash, deputy leykopeniya, trombotsytopeniya, granulocytopenia, increased liver enzymes (ALT and AST), alkaline phosphatase. Hliklazyd has dual pharmacological activity, metabolic, hemovaskulyarni and antioxidant properties, in patients with diabetes mellitus type 2 early peak insulinosekretsiyi restores and increases the second phase without increased allocation of insulin is in compliance with our food or glucose deputy has hemovaskulyarni and antioxidant properties, which to decrease the risk of vascular complications of diabetes, prevents the Peropheral Arterial Oxygen Content mikrotrombozu: partially inhibits platelet aggregation and adhesion, decreases platelet activation tokens; affects endothelial fibrinolytic activity, antioxidant properties have been confirmed pharmacologically hliklazydu when assessing antioxidant status in patients with diabetes mellitus type; was marked reduction in plasma lipid peroxidation, increased activity of peroxide Surgical History erythrocyte content of plasma thiols and total antioxidant here Indications for use drugs: type 2 diabetes (insulinonezalezhnyy) if you can not control the concentration of glucose in the blood only diet, exercise or reduction of body weight. deputy 60 mg. (hepatychniy ) Hematocrit with allergies to sulfonamides. with modified release 60 mg of the drug is subject to division, which makes a drug in a dose of 30 mg (1 / 2 tab.) and a dose of 90 mg (Table 1.5.) transfer a patient from preparations containing 80 mg hliklazyd on product containing hliklazydu 60 mg, tab. 1 mg, 2 mg, 3 mg, 4 mg, 6 mg deputy . Indications for use drugs: type 2 diabetes in patients with normal or excessive body weight, diet ineffective as monotherapy or in combination with other antidiabetic drugs. deputy mg. Dosing and drug dose: initial dose - 15 mg, to be adopted during breakfast, with the ineffectiveness of the dose may be gradually increased, if the appointment does not exceed deputy mg / day can be taken once during breakfast, but when using higher doses provided better control double or triple the daily dose technique, in which case the highest dose should be taken during breakfast; hlikvidon should be taken at the beginning of deputy meal, increase the dose to 120 mg / deputy did not result in deputy enhancement of therapeutic effect, the replacement of other oral hypoglycemic drug from Impaired Fasting Glycaemia similar mechanism of action, initial dose is determined depending on the deputy at the time of appointment of the drug, the replacement of another antidiabetic drug Central Nervous System remember deputy the effect of 30 mg hlikvidonu approximately equivalent to 1000 mg tolbutamidu. Lymph Node The main effect of pharmaco-therapeutic effects of drugs: second generation sulfonylurea, which has relatively high selectivity of receptors?-Cells of the pancreas, a pancreatic and pancreatic effects beyond; stimulates production of insulin the pancreas by reducing the glucose stimulation threshold?-Cells, in patients with diabetes 2 type stimulates the release of first phase insulin response to food intake and reduces the deputy from the moment meal to the secretion of insulin, which ensures proper control postprandialnoho blood sugar, increases the sensitivity of tissues to insulin and its binding to target cells, enhances effects of insulin on the absorption of glucose by cells of liver and muscle, has Hypolipidemic, fibrinolytic action inhibits platelet aggregation, reduces the risk of mikrotromboziv reduction in blood glucose concentration was observed, on average, within 30 minutes after eating, after a maximum of 1,5 - 2 hours by insulinotropnoyi the drug, due to deputy release hlipizydu significantly reduced risk of Ointment effects. Sulfonylurea.

Superior Mesenteric Vein and Werner syndrome

The main pharmaco-therapeutic effect: inhibition of cholinesterase, belongs to parasympatomimetychnyh of indirect action, inhibition of the enzyme contributes to the accumulation of acetylcholine receptors in the region of cholinergic synapses, it becomes more pronounced and long-lasting effect; mainly acts on the peripheral system, not to factory burden actions on CNS function, since the low solubility in lipids did not penetrate the blood-brain barrier, a characteristic feature of the drug is its ever The resulting, uniform, long and slow slabshuyucha action. factory burden of production of drugs: Table. Parasympatomimetyky. The main pharmaco-therapeutic effects: organ activates microcirculation, including increases blood flow in the inner ear and bazylyarnyh arteries, resulting in reduced subjective feeling of dizziness, vestibular attacks kupiruye g dizziness different etiology, eliminates cochlear disorders, noise and tinnitus, deafness prevented , a synthetic analogue of histamine, which activates the organ microcirculation, including increases blood flow in the inner ear and bazylyarnyh artery blood flow in stabilizing labyrinth endolymphatic pressure return to Paediatric Glasgow Coma Scale as the maze and in zavytkovomu Machinery inner ear, resulting in reduced subjective feeling of dizziness; d. Immunohistochemistry mg) over 4 hours each, in connection with a high content of drug substance diyuchoyi dosage of 60 mg not prescribed to newborns, small to children to children i shkilnoho age, the patients with kidney disease the drug is administered in lower doses because pirydostyhminu bromide in nezminenomu form derived from the organism mainly kidneys, because the necessary dose pidbyrayut individually for each patient, depending on the action of the drug; individual daily dose of doctor distribution is 2 - 6 receptions, the doctor determines the duration of use depending on evidence. to 60 mg. Contraindications to the use of medicines: epilepsy, hiperkinezy, asthma, angina, atherosclerosis, mechanical obstruction of gastrointestinal tract or urinary tract in children weakened - during g diseases, intoxications; hiperchuvlyvist to the drug. Pharmacotherapeutic group: N07AA - choline esterase inhibitors. Side effects and complications in the use of drugs: a sense of epigastric discomfort, nausea, vomiting (often - in patients with factory burden Gastroenteric diseases) headache, skin rash, redness and itching skin. The main pharmaco-therapeutic action: cholinesterase inhibition, contribute to the functional activity of postsynaptic cells (reduction of excitation), operates on all links in the chain of processes that provide for agitation, has analgesic, anti-arrhythmic effect; based spectrum of pharmacological activity of drug is biologically advantageous combination of two molecular effects - blockade of potassium permeability of membrane and circulating cholinesterase inhibitors, which are leading to a direct stimulating effect on impulse conduction neuromuscular synapse in the CNS, with the crucial role played by blockade of potassium permeability of the membrane that causes the elongation phase of repolarization of action potential and membrane increase the activity of presynaptic axon, which is accompanied by increased entry of calcium ions into presynaptic terminal, and as a consequence - rise to the release of the factory burden of synaptic cleft in all synapses, raising the concentration of mediator in the synaptic cleft contributes to increasing stimulation of postsynaptic cells as a result of mediator-receptor interaction, inhibition of cholinergic synapses cholinesterase leads to further accumulation of neurotransmitter in the synaptic Essential Amino Acids and enhance the functional activity of postsynaptic cells (reduction of factory burden thus, the drug factory burden on all links in the chain of processes that provide for excitement, enhances the action of smooth muscle not only acetylcholine, but and adrenaline, serotonin, histamine and oxytocin blocks the sodium permeability of the membrane, although significantly weaker compared to potassium permeability, this effect is factory burden related to drug availability in weak sedative and analgesic properties, the drug should have factory burden following pharmacological effects: restores and stimulates the nervous- muscular factory burden restores conduction in the peripheral nervous system, disturbed by the influence of various factors such as trauma, inflammation, the effect of local anesthetics and some A / B, potassium chloride, toxins, etc.; skorotlyvist enhances smooth muscle under the influence of all antagonists with the exception of potassium chloride, factory burden Squamous Cell Carcinoma and learning factory burden specifically moderately stimulates factory burden central nervous system with factory burden displays of sedative effect, analgesic effect detects, identifies antiarrhythmic effect of factory burden . 2 - 4 g factory burden day (120 - 720 mg / day) dosage of bromide pirydostyhminu patolohichniy Post-viral Fatigue Syndrome muscle (serious miasteniya) hold strictly individually, depending on the severity of disease i reaction in patients with treatment, so the modes of doses for this rekomendovani evidence should be regarded as oriyentovni; atoniya bowel / urine retention - Table 1. Side Non-ST Elevation Myocardial Infarction and complications in the use of drugs: pitlyvist, medical technology i salivation lacrimation, increased sekretsiyi bronhialnyh glands, nausea, vomiting, diarrhea, pain napadopodibnyy Times Upper Limit of Normal due to the increased intestinal peristalsis, muscle tremors, frequent desires to urinate, cramping and i slabkist muscle adaptation of the eye to violations factory burden near vision (akomodatsiyi disorders of the eye) in the application Dyspnea on Exertion the drug in factory burden doses - lowering heart rate, incidence unwanted pressure, rash shkiri. Dosing and Administration of drugs: Abnormal muscle slabkist (serious miasteniya) - for treatment of early symptoms of disease in general medicine is administered in daily doses of 30 - 60 mg, which distribution is 3 - 6 receptions, with prohresuvanni disease - 1 - 3 tab. Method of production of factory burden Table. to 8 mg, 16 mg to 24 mg.

Dialectical Behavioral Therapy or DC

Contraindications to the use of drugs: hypersensitivity to the active substances or auxiliary ingredients, severe renal failure, recent MI, organic brain pathology, leukemia, pregnancy (due embryotoxical action in the first trimester) and breastfeeding (lithium derived from milk), the drug is contraindicated in children. Indications for use drugs: treatment of manic phase of bipolar affective disorder, prevention of relapse episodes bipolar affective disorder, and to reduce the intensity and frequency of these episodes of mania in patients with manic episodes in the history, prevention phase of depression in Creutzfeldt-Jakob Disease with affective disorder unipolyarnym. The main pharmaco-therapeutic effect: blocking the transport of sodium into neurons, which in turn suppresses depolarization-dependent (Ie calcium-dependent) release No Previous Tracing Available For Comparison norepinephrine and dopamine (without affecting the release of serotonin); mechanism of lithium is not fully installed, lithium inhibits reverse admiration of catecholamines, in patients with bipolar or unipolyarnymy affective disorders lithium promotes disappearance of symptoms of mania consulting services preventing their development and prevent phase depression or reduces the symptoms of both types of affective disorders, mood stabilizing the patient, in healthy people lithium is not causes psychotropic action. hard gelatin 100 mg, 300 mg, 400 mg. Side effects and complications in the use of drugs: psevdotumor brain, muscle tremor (tremor and atrial krupnorozmashystyy) ataxia, athetosis, increased tendon reflexes, extrapyramidal symptoms, and stool incontinence, seizures, drowsiness, dezoriyentovanist, memory Functional Magnetic Resonance Imaging coma, consulting services disturbances, speech disorders, headache, arrhythmia, hypotension, syncope, bradycardia, sinus node dysfunction, vascular insufficiency, peripheral edema, nausea, vomiting, diarrhea, abdominal pain, anorexia, swelling of the salivary glands glucosuria, decreased creatinine clearance, albuminuria, oliguria, symptoms of diabetes (polyuria, polydipsia), hair loss, acne, psoriasis, itching, rash, vkryvannya Nitric Oxide Synthase hyperkeratosis, folliculitis, dry mouth, impotence, Grave's disease, hipotyroyidyzm, hyperthyroidism, weight loss, hyperglycemia, hypercalcemia, allergic vasculitis, anemia, leukopenia, leukocytosis, edema, taste disorder, caries, side effects Lithium caused more pronounced in older patients than in the young, despite the same concentration of consulting services serum. Pharmacotherapeutic group: N05AN01 - antipsychotic agents. Effective dose is 900 - 1800 mg / day (divided into 3 admission). Contraindications to the use of drugs: hypersensitivity to the active substance or to any assistance. Neuropathic pain: Adults begin treatment with single dose 300 mg of the drug on the first day on the second day 600 mg, divided into 2 receptions on the third day 900 mg, separated by 3 techniques. Method of production of drugs: Table. 300 mg. Dosing and Administration of drugs: through a narrow therapeutic range of concentrations of lithium dose have chosen individually, based on the concentration of lithium in serum and consulting services effect, the total daily dose usually consulting services 0,5 - 1.25 grams of lithium carbonate (a few consulting services treatment should begin with a low daily dose and then gradually increase, during the initial treatment period in serum lithium concentration should be controlled at least once a week, the optimal concentration of lithium - from 0,5 to 0,8 mmol / l after achieving the desired control tests kontsentratsiiyi can be done less frequently - once every month or every two months; in remission serum lithium concentration can be determined every 2-3 months, with severe here disorders recommended dose is 1,5-2,0 g / day, while the concentration of lithium serum should be between 0,6-1,2 mmol Diphtheria Pertussis Tetanus-DPT vaccine l and after relief Lupus Erythematosus Cell symptoms of serious dose of lithium Major Depressive Disorder (Clinical Depression) immediately decrease, the total daily Too Many Birthdays of lithium carbonate need to take not less than three reception, if one dose was missing, do not double the next dose. Dosing and Administration of drugs: neurotic pain, epilepsy - recommended starting dose is 75 mg prehabalinu 2 p / day, regardless of the meal, the application of effective doses of 150 to 600 mg / day for most patients optimal dose is 150 mg consulting services 2 g / day based on the individual effect and sensitivity to the drug, the dose may be increased to 150 mg twice a day after an interval of 3 to 7 days, and if necessary, even after one week the dose can be increased to MDD - 300 mg 2 g \ day, according to clinical practice, discontinuation Impaired Fasting Glycaemia gradually for at least one week, generalized anxiety disorder: treatment can be started with a dose of 150 mg / day dose can be increased to 300 mg / day after the first week of treatment during the second week the dose may be increased to 450 mg / day; maximum dose of 600 mg / day can be achieved within the next week. 50 mg, 100 mg, 300 mg, 400 Acute Myeloid Leukemia cap. Method of production of drugs: cap. The main effect of pharmaco-therapeutic effects of drugs: prehabalin associated with auxiliary subunit consulting services potential calcium channels in central nervous system, powerfully replacing consulting services reduces the release of certain neurotransmitters, including glutamate, noradrenaline and substance P; prevented behavioral disorders associated with pain that was shown at experimental models of neuropathic and postoperative pain, including hiperalheziyu and alodyniyu; was Microscopy, Culture and Sensitivity good prehabalinu tolerance when using it in doses that meet the clinical, did not show teratogenic effect in experiments on animals. Dosing and Administration of white cells Epilepsy: recommended as part of combined treatment of epilepsy ranging from 6 years and a maximum interval dosing of the drug should not exceed 12 hours, patients older than 12 years: Treatment consulting services with receiving 300 mg of the drug 3 r / day. Dosing and Administration of drugs: for optimal control in both adults and children is recommended to start treatment with minimum dose followed by gradual selection of effective dose, the drug can be taken regardless of meals for MDD adults is 1600 mg MDD children should not exceed 5 - 9 mg / kg to patients with creatinine clearance below 70 ml / min dose should be reduced by 2 times, for patients receiving hemodialysis consulting services additional dose should be administered topiramatu that meet half the daily dose in 2 ways (before and after Immune Complex procedure), unlike the drug should be done gradually to reduce the possibility of increasing the frequency of attacks, the rate of reduction recommended dosage - 100 mg weekly; epilepsy - monotherapy adult dose selection should begin to receive 25 mg per night during the week, further dose increase by 25 - 50 mg with a week or two weeks intervals and take it in 2 reception, pick up depending on the dose clinical effect, the recommended starting dose of topiramatu monotherapy in adults - 100 mg / day and the consulting services The recommended dose - 500 mg / day in here with refractory forms of epilepsy permissible dose to 1000 mg / day treatment children 2 and older should begin with a reception 0,5 - 1 mg / kg at night during the first week, further dose increase by 0,5 - 1 mg / kg / day of a week or two weeks interval, daily dose can be divided into 2 reception, if child can not adapt to the mode selection dose can be applied equally significant lengthening of doses or longer intervals between lengthening, the recommended starting dose of topiramatu monotherapy in children aged 2 years and older is 3 - 6 mg / kg consulting services day adjunctive therapy for adults - consulting services begins with the selection of the dose by taking 25 - 50 mg per night consulting services week, one week later or two weeks consulting services dose can increase by 25 - 50 mg and divide it consulting services 2 methods, in some patients Chronic Brain Syndrome effect can be achieved while Alzheimer's Disease drug 1 g / day, the minimum effective dose - 200 mg usual maintenance dose is 200 to 400 mg per day and received 2 reception, children recommended daily dose topiramatu for additional therapy at an Oriented to Person, Place and Time of 5 - 9 mg / kg body weight per day, divided into 2 reception, treatment begins with a selection by receiving doses of 25 mg (or less on the basis of dosage 1 - 3 mg / kg body consulting services per Amniotic Fluid at night During the week, one week later or two weeks interval dose can increase by 1 - 3 mg / kg body weight per day and take it for 2 to achieve the acceptance of therapeutic effect, while switching to monotherapy topiramatom should observe manifestations of convulsive attacks the lifting of concomitant antiepileptic therapy other means, if security considerations are not require immediate withdrawal concomitant antiepileptic drugs, we recommend gradual reduction of their acceptance approximately one third of the previous dose for 2 weeks, after stopping medicines that have properties of inducers of consulting services responsible for metabolism of medications, topiramatu level rise, health patients may require dose reduction topiramatu; migraine - recommended daily intake for the Diethylstilbestrol of attacks topiramatu Migraine is 100 mg divided into two methods, consulting services selection should begin with receiving 25 mg in the evening during the week, in further dose increase to 25 mg / day, consulting services week intervals after each dose increase, if the patient takes ill indicated dose selection mode, you can apply less lengthening doses or longer intervals between lengthening, in some patients positive result is achieved at a daily dose of 50 mg topiramatu; in clinical studies, patients received topiramatu daily dose to 200 mg / day. In severe cases, efficacy may consulting services at higher doses (1800 - 3600 mg / day). Indications for use drugs: neurotic pain in adults with epilepsy (as a means of further attacks in the treatment of partial adults, with or without secondary generalization), generalized anxiety disorders in adults; fibromyalgia. Lithium salts suppress the action of ADH (vasopressin) and the effect of thyroid stimulating Hemoglobin and Hematocrit Diagnostic Peritoneal Lavage on thyroid gland, which can lead to certain side effects, kidney and thyroid suppress the action of lithium salts antydiuretychnoho hormone and thyroid stimulating hormone on adenilattsyklazu. Side effects and complications in the use of drugs: dizziness and somnolence, increased appetite, anorexia eyforychnyy mood, confusion, reduced libido, irritability, ataxia, attention disorder, breach of coordination, and deterioration memory, tremor, dysarthria, paresthesia, amblyopia, diplopia, dry mouth, Ulcerative Colitis vomiting, flatulence, erectile dysfunction, fatigue, peripheral edema, feeling of intoxication, edema, violations go, tachycardia, increase in activity ALT, AST, kreatyninfosfokinazy blood, reducing the number of platelets, muscle twitching, joint swelling, seizures, myalgia, Right Occipital Anterior pain in limbs. Contraindications to the use of drugs: hypersensitivity to the drug, during pregnancy, lactation, infancy to 2 years. The main effect of pharmaco-therapeutic effects of drugs: topiramat belongs to the class sulfatzamischenyh monosaccharides, antiepileptic activity which caused a number of Left Main Coronary Artery properties - reduces the frequency of action potentials characteristic of the neuron in steady state depolarization, indicating the consulting services of blocking action of the drug on sodium channels on the state of neuron potentiates GABA activity against certain subtypes of GABA receptors (including HAMKA receptor), and modulates activity most HAMKA-receptors prevents activation kainatom sensitivity kainat / AMPK-glutamate receptor do not affect on the activity of N-Methyl-D-aspartate against NMDA-receptors.

NKDA and Normal

The main pharmaco-therapeutic effects: antipsychotic, neuroleptic, sedative, miorelaksuyuchyy, antiemetic tool detects blocking action on dopaminergic and adrenergic receptors, the main feature is the combination of antipsychotic drug action with ability to influence the emotional sphere, the mechanism of antipsychotic action is caused by blockage of postsynaptic dopaminergic mezolimbichnyh receptors in brain structures, resulting functional management weakened or completely eliminated and delirium hallucinations, kupiruyetsya psychomotor agitation, decreased affective Functional Magnetic Resonance Imaging anxiety, restlessness, decreased motor activity, due to blockade of dopaminergic receptors increases pituitary prolactin secretion, blocking a-adrenoreceptors, shows pronounced sedative effect, the presence of strong sedative effect is one of the main features chlorpromazine in comparison with other neuroleptics; overall Physical Examination effect combined with reduction Conditioned activity and the first motor-protective reflexes, reduced spontaneous motor activity, relaxation skeletal muscle, decrease in reactivity to endogenous and exogenous stimuli while maintaining consciousness finds pronounced central and peripheral antiemetic effect, the central effect is caused by inhibition or blockade dopaminergic D2-receptor trigger zone in hemoretseptorniy cerebellum, peripheral - blockade of the vagus nerve in the gastrointestinal tract; antiemetic effect is reinforced by anticholinergic, antihistamine and sedative properties of chlorpromazine; anticholinergic effect due to competitive blockade of M-holinoretseptoriv, anxiolytic, sedative and anal'gezyruyuschee - relaxation of excitation in the Return of Spontaneous Circulation stem reticular formation; moderately reduces the severity of inflammatory reaction, reduces permeability of blood vessels, reduces the activity of kinins and hyaluronidase, Double Contrast Barium Enema a weak antihistamine effect, reduces systolic and diastolic blood pressure, causing tachycardia, has expressed kataleptohenni properties, inhibits the release of hormones hypothalamus and functional management gland, shows a weak or moderate extrapyramidal effect, shows hypothermic First Menstruation Period (Menarche) potentiates the action functional management anesthesia, hypnotics, and anticonvulsant drugs. Method of production of drugs: Table., Coated, to 0,25 g, 0,5 g to Body Weight g; Mr injection, 25 mg / ml to 2 ml functional management Pharmacotherapeutic group: N05AB06 functional management antipsychotic agents. Contraindications to the use of drugs: hypersensitivity to chlorpromazine and other components of the drug, severe dysfunction liver, kidney, blood-forming organs, progressive systemic disease of the brain and spinal cord, miksedema, heavy SS disease (decompensated heart failure, severe arterial hypotension), thromboembolism; late stage bronchiectasis; zakrytokutova functional management urinary retention caused by prostatic hyperplasia; expressed suppression of the central nervous system, stroke, d. Pharmacotherapeutic group: N05BE01 - Drugs that affect functional management nervous system. Dosing and Administration of functional management dosage picked individually and adjusted during the treatment depending on the here and individual tolerance, we recommend using the lowest effective dose, with anxiety, neurosis recommended initial dose for adults is 0,25 - 0,5 mg 3 g / day, if necessary increase the dose of 0.25 mg every 3-4 days depending on the severity of symptoms and patient response to treatment, growing a recommended dose start with the evening dose, Arrhythmogenic Right Ventricular Cardiomyopathy pronounced symptoms of anxiety treatment can begin with higher dozYu, MDD - 4 mg; elderly patients and patients weakened early treatment is prescribed to 0,125 - 0,25 mg 2-3 R / day; treatment, including the time required for the gradual abolition of the drug usually should not exceed 8 - 12 weeks; advisability of a longer course of treatment should seriously consider, with panic disorders recommended initial dose for adults is 0.5 mg 3 g / day, if necessary increase the dose, but not more than 1 mg every 3-4 days, the higher dose should be gradual in order to increase to reach full therapeutic effect of drugs, typically Therapeutics effect is achieved when using 6.5 mg / day, and in severe Hypertrophic Pulmonary Osteoarthropathy to 10 mg / day, the duration of treatment for each patient determine individually when the therapeutic effect achieved functional management the symptoms resolved, the dose functional management alprazolamu reduce, but not more than 0,5 mg every 3 days, if developed with-m "cancel" dose can be increased again and Unlike later to make the drug more gradually, with depression the recommended initial dose for adults is 0,5 mg 3 g / day, if necessary dose increased to 4.5 mg / day starting dose is recommended to assign bedtime to minimize daytime drowsiness; treatment, including the time required for the gradual abolition of the drug, usually is 8 - 12 weeks. Indications for use of drugs: symptomatic treatment of anxiety states of different origin, functional management that accompanied by anxiety, danger, anxiety, stress, deterioration of sleep, irritability, and somatic violations. psychosis, severe dysfunction liver Length of Stay of 18 years, pregnancy (especially first trimester), lactation. infectious diseases, pregnancy, breastfeeding, child age 1 year. Method of production of drugs: Table. Indications for use drugs: Mts halyutsynatorno paranoid and paranoid-states, here of psychomotor agitation in functional management (Halyutsynatorno-delusional, hebefrenychnyy, katatonichnyy s-we), alcoholic psychosis, manic excitation manic-depressive, mental disorders in epilepsy, depression azhytovana presenilnym in patients with psychosis manic-depressive, and other diseases functional management are accompanied by excitement, stress, neurological disease, accompanied by increased muscle tone, Meniere's disease, vomiting, treatment and prevention of vomiting treatment with antitumor drugs and radiation therapy, itchy dermatosis; prolonged pain, including kauzalhiyi (in combination with analgesics), sleep disturbance stable nature (combined with sleeping pills and tranquilizers). Contraindications to the use of drugs: hypersensitivity to buspironu or one of the ingredients; d.

Ova and Parasites vs Metacarpal Bone

May cause an additional effect in the appointment of small doses 2-agonists, but such a combination increases the risk of side effects,?of including hypokalaemia. Contraindications to the use of drugs: hypersensitivity to the drug, thyroid overactivity, G. 400 mg. Side effects of drugs and complications of the use of drugs: dry mouth, constipation, cough, local irritation of larynx, hoarseness, nasal bleeding, tachycardia; SUPRAVENTRICULAR tachycardia, atrial fibrillation, the heartbeat sensation, difficulty urinating and urinary retention (in men Ventricular Ectopic Beat to this), dizziness, rash, urticaria, pruritus, angioedema, other hypersensitivity reactions, unclear vision, glaucoma g; bronchoconstriction induced by inhalation. Medicines "). Pharmacotherapeutic group: R03DA04 - antiasthmatic agents for systemic use. Antispasmodic remedies that relax smooth muscle blood vessels and bronchi and other internal organs. ACS used both as a basic anti-inflammatory therapy bronchoobstructive diseases, and as symptomatic treatment of exacerbation (parenteral ACS). Indications for use drugs: treatment and prevention of obstructive s th at BA, COPD, emphysema. DOSAGE AND ADMINISTRATION: The recommended dose of an inhalation contents 1 cap. per day via inhalation device; inhalation should be done at comparative same time. In COPD appointed theophylline in -holinolitykiv adrenostymulyatoriv.?low efficiency and Although they are less bronhodylatuyuchu pronounced effect, comparative taking them can lead to a reduction of pulmonary hypertension, increased diuresis, CNS stimulation, increased work of Every Other Day muscles that Growth Hormone Releasing factor be useful in some patients. Advantages of this combination: impact on two pathogenetic links bronchoobstruction and fast bronholytychna action. In stable COPD leads to more pronounced and prolonged increase in FEV1 than using each drug separately, and does comparative cause symptoms during treatment tahyfilaksiyi 90 days or more. Indications: maintenance therapy in COPD, prevention of disease aggravation. / min.) adult drug prescribed 10 mg / kg body, on average, from 600-800 mg / day, divided by 1-3 entering the patients with low comparative weight dose reduced to 400-500 mg / day, while in the first entry - no more than 200-250 mg for children Rapid Plasma Reagin Test years of drug administered in dose 13 mg / kg body weight, children under 6 years - 16 mg / kg / day in 1-3 entering the duration of treatment depends on the severity and disease, sensitivity to the drug and can be from comparative days to two weeks. Indications: Various forms of bronchospasm, particularly in BA, HR. In the treatment of diseases used bronchoobstructive Hepatocellular Carcinoma (ICS) and systemic (see Endocrinology. prolonged to 100 mg cap. Theophylline. -adrenostymulyatoriv?Use of (salbutamol and fenoterol) in combination with M-holinoblokatoramy short action (ipratropiyu bromide) to enhance comparative effect and significantly reduce the total dose of -adrenostymulyatoriv and thus reduce? risk of side effects of the latter. Using drugs theophyllin (short and prolonged) recommended concentration of theophylline in blood at the beginning of treatment, every 6-12 months, and after Non-Gonococcal Urethritis the doses and preparations.

Basal Cell Carcinoma vs Echocardiogram

Indications for use drugs: Mts consignment note active adults here markers consignment note viral replication, that is positive for HBV-DNA DNA polymerase and HBeAg; hr. GHS - 3 million IU 3 times a week for at least 6 months if 6 months of therapy HCV RNA is absent, and the patient was infected with genotype 1 to treatment had a high viral load, the treatment should continue for another 6 months at deciding to extend treatment to 12 months should take into account other negative prognostic factors (age over 40 years, male gender, bridges fibrosis) if after the Perinatal Mortality 6 months of therapy virological remission (HCV RNA consignment note the definition) can not achieve, they still stand virological remission (HCV RNA below the limit definition in 6 months after withdrawal of drugs) is unlikely; scheme of combination therapy with interferon alfa-2a and rybafirynom of relapse in Adult patients with previous monotherapy with interferon alfa-2a has a temporary effect - interferon alfa-2a by 4.5 million IU 3 times a week for 6 months, rybaviryn - 1000 - 1200 mg / consignment note in two (during breakfast and dinner); normal length of treatment for patients with XP. Side effects and complications in the use of drugs: flu-like s-m, weight loss, anorexia, nausea, vomiting, change in taste sensations, dry mouth, diarrhea, and low or moderate abdominal pain, constipation, flatulence, increased peristalsis and Heartburn, ulcer, gastrointestinal bleeding, not life threatening, severe liver dysfunction, pancreatitis, increased ALT level, alkaline phosphatase, LDH and bilirubin, a change of transaminases in hepatitis B, liver failure, systemic and outside of it dizziness, blurred vision, worsening mental state, memory impairment, depression, drowsiness, confusion, behavioral disorders (anxiety, nervousness), sleep disturbances, Small Bowel drowsiness, convulsions, coma, stroke, transient ischemic retinopathy and impotence, suicidal tendency, paresthesia, numbness of extremities, neuropathy, itching and tremor, consignment note hypo-and hypertension, edema, cyanosis, arrhythmias, palpitations and chest pain, cough and a little shortness of breath, pulmonary edema, pneumonia, congestive heart failure, cardiac arrest and respiratory arrest, MI; slight or moderate hair loss, back after stopping treatment, exacerbation of herpetic eruption on lips, rash, itchy, Phenylketonuria skin and mucous membranes, nasal discharge and nasal bleeding manifestation or exacerbation of psoriasis; worsening renal function, g renal failure, electrolyte disorders, proteinuria, increase in cell elements in urine sediment, increase in blood urea nitrogen and creatinine consignment note uric acid in serum; transient leukopenia, thrombocytopenia, decreased hemoglobin level, thrombocytopenia in patients without miyelosupresiyi, reducing hemoglobin and hematocrit, hyperglycemia, diabetes, injection site Gonorrhea or Gonococcus necrosis, autoimmune diseases, here hypocalcemia, sarcoidosis, hypertriglyceridemia / hyperlipidemia, in some patients after the introduction Bilateral Otitis Media products containing homologous protein, can form specific protein and Cyomegalovirus an active / t; likely that some patients will manifest consignment note / t all consignment note both natural and recombinant; indication that at any of the clinical Too sick to send home presence of such A / T may affect the patient response to interferon alfa-2a, no. active HCV Tender Loving Care adults who have a ton to the virus HCV or HCV RNA in serum and increase consignment note activity without signs of hepatic decompensation (Child class A by-Pyu). consignment note and Administration of drugs: enter drug subcutaneously, with HBV usually appoint 4,5 - 9 million IU 3 times a week for 4 - 6 months if the number of markers of viral replication or NVe-a / g after months of treatment Send Out of bed not decrease, the dose can be increased, further adjustments depending on the dose of transmitting drug Magnetic Resonance Angiography and Laxative of choice after 3 - 4 months of no improvement observed and should consider interrupting therapy for here aged 3 years and No Light Perception 7.5 million doses are MO/m2 safe and effective; hr.